Evidence map›Paper›PMID 39078061›Full record

ArticleJournal of addiction medicine

Experience Starting an Addiction Medicine Practice-based Research Network.

Adila Ibrahim, Diana E Clarke, Debbie Gibson, Barbara Casanova, Anna Pagano, Frank J Vocci, Amy Goldstein, Sejal Patel, Nusrat Rahman, Robert P Schwartz

Abstract read
In one paragraph

Article in Journal of addiction medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Adila IbrahimFrom the Friends Research Institute, Baltimore, MD (AI, FJV, RPS); Division of Research, American Psychiatric Association, Washington, DC (DEC, DG, BC, SP, NR); Quality and Science Department, American Society for Addiction Medicine, Rockville, MD (AP); Division of Epidemiology, Services and Prevention Research, National Institute on Drug Abuse, Bethesda, MD (AG); and Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (DEC).ORCID 0000-0003-2860-1855
Diana E Clarke
Debbie Gibson
Barbara Casanova
Anna Pagano
Frank J Vocci
Amy Goldstein
Sejal Patel
Nusrat Rahman
Robert P Schwartz

Funding

Facilitating the Implementation of Interim Methadone to Increase Treatment Access: A Multi-Site Implementation TrialU01DA046910 · NIDA · FRIENDS RESEARCH INSTITUTE, INC. · PI SCHWARTZ, ROBERT P · 2018 to 2021
$4.8M
NIDA NIH HHS U01 DA046910
6 · The paper itself

Abstract

objectivesThis paper outlines the experience developing Addiction Medicine Practice-Based Research Network (AMNet), which promotes the adoption of patient-reported outcome measures (PROMs) and measurement-based care in outpatient addiction treatment practices and creates a platform for quality improvement and research.

methodsFrom August 2019 to July 2023, the AMNet team selected patient-reported outcome measures for implementation in the American Psychiatric Association's clinical data registry (PsychPRO), recruited addiction medicine providers, and collected PROMs data.

resultsAMNet selected 12 PROMs for implementation in PsychPRO. Through July 2023, 1565 providers expressed interest, of whom 216 of the 929 eligible providers (23%) attended an onboarding call/webinar. Two hundred six providers (95%) from 54 practices returned Participation Agreements. Subsequently, 65 providers (32%) from 39 practices withdrew, resulting in 141 (68%) providers from 15 practices. From November 2020 to July 2023, 38 providers submitted PROMs data using 1 of 3 PsychPRO patient portals. Sixteen of the 53 providers (30%) who signed up for the initial portal collected data from 468 patients. As of July 2023, 83 of the 141 providers (59%) opted to submit PROMs data from their own portal or electronic health record.

conclusionsNext steps will include continued recruitment of providers, addressing barriers to data transfer and integrating data from providers' portals into the registry to create a platform for future research.

Indexed as

Addiction MedicinePatient Reported Outcome MeasuresHumansQuality ImprovementRegistriesSubstance-Related DisordersUnited States

Identifiers

PMID39078061
PMCPMC11537816

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.